RNAi-based β-catenin inhibition in combination with MEK inhibition promotes synergistic anti-tumor efficacy and overcomes resistance with MEK inhibition promotes synergistic anti-tumor efficacy and overcomes resistance

被引：0
|
作者：
Ganesh, Shanthi
Shui, Serena
Chopda, Girish
Koser, Martin
Craig, Kevin
Dutta, Chaitali
Lai, Cheng
Dudek, Hank
Wang, Weimin
Brown, Bob D.
Abrams, Marc
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1229
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1229
引用
收藏
页数：2
相关论文
共 50 条
  • [1] NEURONAL DIFFERENTIATION DRIVES THE ANTI-TUMOR EFFICACY OF MEK INHIBITION IN GLIOBLASTOMA
    Khan, Sabbir
    Martinez-Ledesma, Emmanuel
    Park, Soon Young
    Dong, Jianwen
    Piao, Yuji
    Harrison, Erin
    Koul, Dimpy
    Balasubramaniyan, Veerakumar
    De Groot, John
    Yung, W. K. Alfred
    NEURO-ONCOLOGY, 2022, 24 : 24 - 24
  • [2] β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models
    Ganesh, Shanthi
    Shui, Xue
    Craig, Kevin P.
    Koser, Martin L.
    Chopda, Girish R.
    Cyr, Wendy A.
    Lai, Chengjung
    Dudek, Henryk
    Wang, Weimin
    Brown, Bob D.
    Abrams, Marc T.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (02) : 544 - 553
  • [3] MEK BLOCKADE SYNERGISTICALLY INCREASES THE ANTI-TUMOR EFFECTS OF MTOR INHIBITION IN GLIOMAS
    Zhang, Jie
    Liu, Kevin
    Dik, Rogier
    Yang, Xiaodong
    Waanders, Angela
    Resnick, Adam
    Wright, Karen
    Weiss, William
    Haas-Kogan, Daphne
    Mueller, Sabine
    NEURO-ONCOLOGY, 2019, 21 : 121 - 121
  • [4] MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity
    Yarchoan, Mark
    Mohan, Aditya A.
    Dennison, Lauren
    Vithayathil, Teena
    Ruggieri, Amanda
    Lesinski, Gregory B.
    Armstrong, Todd D.
    Azad, Nilofer S.
    Jaffee, Elizabeth M.
    PLOS ONE, 2019, 14 (10):
  • [5] RNAi-mediated ß-catenin inhibition promotes T-cell infiltration and anti-tumor activity in combination with immune checkpoint blockade
    Ganesh, Shanthi
    Shui, Serena
    Wang, Weimin
    Brown, Bob D.
    Abrams, Marc
    CANCER RESEARCH, 2017, 77
  • [6] Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines
    Ma, Yixuan
    Schulz, Benjamin
    Trakooljul, Nares
    Al Ammar, Moosheer
    Sekora, Anett
    Sender, Sina
    Hadlich, Frieder
    Zechner, Dietmar
    Weiss, Frank Ulrich
    Lerch, Markus M.
    Jaster, Robert
    Junghanss, Christian
    Escobar, Hugo Murua
    CANCERS, 2022, 14 (18)
  • [7] HIF-1α Inhibition Improves Anti-Tumor Immunity and Promotes the Efficacy of Stereotactic Ablative Radiotherapy (SABR)
    Song, Chang W.
    Kim, Hyunkyung
    Cho, Haeun
    Kim, Mi-Sook
    Paek, Sun-Ha
    Park, Heon-Joo
    Griffin, Robert J.
    Terezakis, Stephanie
    Cho, Lawrence Chinsoo
    CANCERS, 2022, 14 (13)
  • [8] Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
    Cheng, Yang
    Luo, RongCheng
    Zheng, Hang
    Wang, Biao
    Liu, YaHui
    Liu, DingLi
    Chen, JinZhang
    Xu, WanFu
    Li, AiMin
    Zhu, Yun
    ONCOTARGET, 2017, 8 (14) : 23265 - 23276
  • [9] Inhibition of N-cadherin enhances anti-tumor activity and overcomes chemoresistance in regional melanoma therapy
    Augustine, C. K.
    Yoshimoto, Y.
    Zipfel, P. A.
    Selim, M. A.
    Tyler, D. S.
    EJC SUPPLEMENTS, 2006, 4 (12): : 115 - 115
  • [10] Combination of magnetic targeting with synergistic inhibition of NF-κB and glutathione via micellar drug nanomedicine enhances its anti-tumor efficacy
    Elhasany, Kholod A.
    Khattab, Sherine N.
    Bekhit, Adnan A.
    Ragab, Doaa M.
    Abdulkader, Mohammad A.
    Zaky, Amira
    Helmy, Maged W.
    Ashour, Hayam M. A.
    Teleb, Mohamed
    Haiba, Nesreen S.
    Elzoghby, Ahmed O.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2020, 155 : 162 - 176
12345